Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 437.20
Bid: 436.60
Ask: 437.20
Change: -12.20 (-2.71%)
Spread: 0.60 (0.137%)
Open: 450.60
High: 450.60
Low: 434.20
Prev. Close: 449.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

30 Sep 2015 07:00

RNS Number : 6226A
QinetiQ Group plc
30 September 2015
 

 

News release

QinetiQ Group plc

 

Pre Close Trading Update

 

Ahead of QinetiQ entering its closed period for the half year ending 30 September 2015, we will be holding our customary pre-close meetings with analysts today. No new material information will be disclosed in these meetings.

The Board is maintaining its expectations for Group performance this financial year.

In the UK, the Government's Strategic Defence and Security Review (SDSR), and public consultation on the proposed approach to calculating the baseline profit rate for single source contracts, are both underway.

The EMEA Services division continues to see some customer contract award decisions deferred due to uncertainties in the UK market or delayed by requirements for additional approvals. However, revenue under contract for this financial year is as expected at this stage.

As anticipated, the Group's Global Products division continues to trade at similar levels to the prior year.

QinetiQ's interim results for the half year ending 30 September 2015 will be announced on 19 November 2015.

ENDS

 

Notes to Editors:

A FTSE250 company, QinetiQ uses its world class knowledge, research and innovation to provide high-end technical expertise and advice, to customers in the global aerospace, defence and security markets. QinetiQ's unique position enables it to be a trusted partner to government organisations, predominantly in the UK and the US, including defence departments as well as other international customers in targeted sectors. For more information see www.QinetiQ.com.

For further information please contact:

Investor relations:

David Bishop, QinetiQ

+44 (0) 7920 108675

Media relations:

QinetiQ press office

+44 (0) 1252 393500

Rebecca Mitchell, Maitland

+44 (0) 207 379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVRATIAFIE
Date   Source Headline
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPre-close Trading update
21st Sep 20203:57 pmRNSDirectorate Change
10th Sep 202010:29 amRNSDirector/PDMR Shareholding
20th Aug 20202:14 pmRNSHolding(s) in Company
13th Aug 20204:47 pmRNSDirector/PDMR Shareholding
11th Aug 202011:56 amRNSDirector/PDMR Shareholding
10th Aug 202011:28 amRNSTotal Voting Rights
4th Aug 20203:59 pmRNSBlock Listing Application
31st Jul 202012:50 pmRNSTransfer of Treasury Shares & Total Voting Rights
14th Jul 20202:00 pmRNSResult of Annual General Meeting
14th Jul 20207:00 amRNSQ1 Trading Update and Acquisition of Naimuri
13th Jul 20203:51 pmRNSQinetiQ enters next phase of growth in the US
10th Jul 202011:52 amRNSDirector/PDMR Shareholding
1st Jul 202010:50 amRNSDirector/PDMR Shareholding
1st Jul 202010:49 amRNSTotal Voting Rights
1st Jul 202010:46 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSDisposal of Boldon James to HelpSystems
23rd Jun 202011:46 amRNSDirector/PDMR Shareholding
12th Jun 202010:48 amRNSAnnual Financial Report
10th Jun 202012:31 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSPreliminary Results
19th May 20204:05 pmRNSDirectorate Change
12th May 202011:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.